South Dakota Investment Council’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,690
Closed -$113K 597
2021
Q3
$113K Sell
2,690
-44,000
-94% -$1.58M ﹤0.01% 563
2021
Q2
$1.81M Hold
46,690
0.03% 373
2021
Q1
$1.59M Buy
46,690
+41,490
+798% +$1.77M 0.03% 406
2020
Q4
$236K Hold
5,200
﹤0.01% 573
2020
Q3
$143K Hold
5,200
﹤0.01% 572
2020
Q2
$192K Hold
5,200
﹤0.01% 554
2020
Q1
$168K Hold
5,200
﹤0.01% 537
2019
Q4
$213K Hold
5,200
﹤0.01% 543
2019
Q3
$185K Buy
5,200
+1,600
+44% +$64.8K ﹤0.01% 577
2019
Q2
$185K Hold
3,600
﹤0.01% 562
2019
Q1
$206K Hold
3,600
﹤0.01% 559
2018
Q4
$151K Hold
3,600
﹤0.01% 576
2018
Q3
$272K Buy
+3,600
New +$259K 0.01% 568

Other funds holding RGNX

South Dakota Investment Council's RGNX Position: Q4 2021 in Review

South Dakota Investment Council sold out of Regenxbio (RGNX) in Q4 2021, closing a stake of 2,690 shares — an estimated $113K sold.

South Dakota Investment Council first reported a position in RGNX in Q3 2018 and held it in 13 quarters. The position peaked at $1.81M in Q2 2021. 172 funds tracked by Wall St. Rank hold RGNX as of Q4 2021.

  • South Dakota Investment Council reported no remaining Regenxbio position as of Q4 2021 after selling out during the quarter.
  • South Dakota Investment Council sold 2,690 Regenxbio shares in Q4 2021, an estimated $113K.
  • South Dakota Investment Council first reported a position in Regenxbio in Q3 2018 and held it in 13 quarters.
  • South Dakota Investment Council's Regenxbio position peaked at $1.81M in Q2 2021.
  • 172 funds tracked by Wall St. Rank held Regenxbio as of Q4 2021.

Based on South Dakota Investment Council's 13F filing for Q4 2021, filed 8 Feb 2022.